Chemomab Therapeutics Names David M. Weiner, MD as Interim Chief Medical Officer - read this article along with other careers information, tips and advice on BioSpace
/PRNewswire/ Chemomab Therapeutics Ltd. (NASDAQ: CMMB), (Chemomab) a clinical-stage biotech company focused on the discovery and development of innovative.
/PRNewswire/ Chemomab Therapeutics Ltd. (NASDAQ: CMMB), (Chemomab) a clinical-stage biotech company focused on the discovery and development of innovative.
/PRNewswire/ Chemomab Therapeutics Ltd. (NASDAQ: CMMB), (Chemomab) a clinical-stage biotech company focused on the discovery and development of innovative.